Published in Am J Epidemiol on March 01, 1972
Analysis of a measles epidemic; possible role of vaccine failures. Can Med Assoc J (1975) 1.29
The duration of immunity in cattle following inoculation of rinderpest cell culture vaccine. J Hyg (Lond) (1984) 0.83
Measles vaccine: a 27-year follow-up. Epidemiol Infect (1994) 0.79
High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases. Clin Vaccine Immunol (2016) 0.79
Controversies in viral immunization. Can Fam Physician (1979) 0.78
Measles in a partially immunized community. Am J Public Health (1979) 0.76
Evaluation of live attenuated measles vaccines prepared in human diploid cells for reimmunization. Epidemiol Infect (1988) 0.75
Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic. Bull World Health Organ (1975) 0.75
Antimicrobial treatment of pertussis. J Pediatr (1969) 3.77
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol (1994) 3.05
The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest (1995) 2.65
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Use of pertussis vaccine in an epidemic involving hospital staff. Lancet (1975) 2.15
The carrier state in pertussis. Am J Epidemiol (1968) 1.86
Pertussis: persistent problems. J Pediatr (1974) 1.69
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis (1982) 1.64
Bordetella parapertussis. Recent experience and a review of the literature. Am J Dis Child (1977) 1.60
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid. Chest (1994) 1.48
Pathogenesis of varicella-zoster angiitis in the CNS. Arch Neurol (1980) 1.45
Yersinia enterocolitica infections in hospitalized patients: the problem of hospital-acquired infections. Infect Control Hosp Epidemiol (1992) 1.43
Transmission of herpes-simplex virus type 1 in a nursery for the newborn. Identification of viral isolates by D.N.A. "fingerprinting". Lancet (1978) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Recurrent epidemics caused by a single strain of erythromycin-resistant Staphylococcus aureus. The importance of molecular epidemiology. JAMA (1993) 1.30
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol (1982) 1.28
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Letter: HBAg in breast milk. Lancet (1974) 1.25
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Measles vaccine: immunity, reinfection and revaccination. Am J Epidemiol (1973) 1.22
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Treatment of Chlamydia trachomatis infections: comparison of 1- and 2-g doses of erythromycin daily for seven days. Sex Transm Dis (1987) 1.08
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med (1986) 1.04
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics (1975) 1.04
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Measles immunity after revaccination: results in children vaccinated before 10 months of age. Pediatrics (1982) 1.03
Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers. Antiviral Res (1989) 1.02
Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child (1972) 1.02
Screening hospital patients for hepatitis B surface antigen. Am J Clin Pathol (1977) 1.01
Polytetrafluoroethylene graft survival in hemodialysis. JAMA (1983) 1.00
Risk of pneumococcal infections in renal transplant patients. JAMA (1979) 0.98
Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella. Am J Dis Child (1965) 0.98
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Rubella: recent laboratory and clinical advances. Prog Med Virol (1966) 0.98
Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis (1975) 0.97
Protection of adults rechallenged with a human rotavirus. J Infect Dis (1990) 0.97
Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol (1996) 0.96
Fatal viral encephalitis in children with X-linked hypogammaglobulinemia. Am J Dis Child (1973) 0.96
Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. Am J Dis Child (1975) 0.96
Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees. Am J Dis Child (1969) 0.95
Rubella: studies on the natural disease. The significance of antibody status and communicability among young women. Am J Dis Child (1965) 0.94
Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis (1992) 0.94
Staphylococcus lugdunensis endocarditis after tooth extraction. Clin Infect Dis (1995) 0.94
Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease. J Clin Microbiol (1998) 0.94
Pertussis in the adult. Annu Rev Med (1977) 0.94
Tick-borne relapsing fever in the Eastern United States. Am J Dis Child (1978) 0.93
Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis (1990) 0.93
Pathogenicity of stable L-phase variants of Staphylococcus aureus: failure to colonize experimental endocarditis in rabbits. Infect Immun (1973) 0.92
Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections. Infect Immun (1974) 0.91
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
Decline of clinical hepatitis B in workers at a general hospital: relation to increasing vaccine-induced immunity. Clin Infect Dis (1993) 0.91
Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90
Experimental rubella. Clinical and laboratory findings. Arch Intern Med (1965) 0.89
Chlamydia trachomatis cervical infections in female adolescents. J Pediatr (1981) 0.89
Influenza in ferrets and guinea pigs: effect on cell-mediated immunity. Infect Immun (1978) 0.88
Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest (1990) 0.88
Risk of infection associated with a wastewater spray irrigation system used for farming. J Occup Med (1984) 0.87
The clinical presentations of Rocky Mountain spotted fever. Comments on recognition and management based on a study of 63 patients. Clin Pediatr (Phila) (1978) 0.87
Induction and persistence of local rotavirus antibodies in relation to serum antibodies. J Med Virol (1989) 0.87
Fatal rhabdomyolysis associated with parainfluenza type 3 infection. Hiroshima J Med Sci (1978) 0.87
Punctate outer retinitis in acute Epstein-Barr virus infection. Am J Ophthalmol (1987) 0.87
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers. Vaccine (2001) 0.86
Challenge with rubella virus after loss of detectable vaccine-induced antibody. Rev Infect Dis (1985) 0.86
Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection? Arch Intern Med (1978) 0.85
Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J Med Virol (1991) 0.85
Evaluation of a live, attenuated recombinant influenza vaccine in high school children. Infect Immun (1975) 0.85
Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella. Am J Dis Child (1969) 0.85